Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 70 | 0 | 0 | 0 |
| Gross Profit | N/A | 70 | N/A | N/A | N/A |
| Operating Expenses | 4,414 | 4,938 | 5,847 | 5,949 | 5,336 |
| Operating Income | -4,414 | -4,868 | -5,847 | -4,949 | -5,336 |
| Other Income | 165 | 209 | 161 | 339 | 406 |
| Pre-tax Income | -4,249 | -4,659 | -5,686 | -4,610 | -4,930 |
| Income Tax | N/A | N/A | -962 | N/A | N/A |
| Net Income Continuous | -4,249 | -4,659 | -4,724 | -4,610 | -4,930 |
| Net Income | $-4,249 | $-4,659 | $-4,724 | $-4,610 | $-4,930 |
| EPS Basic Total Ops | -0.49 | -0.54 | -0.55 | -0.55 | -0.59 |
| EPS Basic Continuous Ops | -0.49 | -0.54 | -0.55 | -0.55 | -0.59 |
| EPS Diluted Total Ops | -0.49 | -0.54 | -0.55 | -0.55 | -0.59 |
| EPS Diluted Continuous Ops | -0.49 | -0.54 | -0.55 | -0.55 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.54 | -0.55 | -0.55 | -0.59 |
| EBITDA(a) | $-4,384 | $-4,844 | $-5,845 | $-5,987 | $-5,385 |